DNAlite Therapeutics, Inc. is an early-stage preclinical biotechnology company committed to bringing the next-generation of drugs to organs protected by mucus barriers.
An alternative to INvasive surgeries
Diseases such as FAP, colorectal cancer, and Crohn's disease are currently treated with complete or partial removal of the colon and/or rectum.
Treating the Cause of disease
Our aim is to prevent, rather than manage the progression of these diseases.
We are harnessing our proprietary non-viral vector gene therapy, to carry DNA to cells that drive these diseases.